已發(fā)表的部分文獻(xiàn): 標(biāo)題:All-trans retinoic acid and sodium butyrate enhance natriuretic peptide receptor a gene transcription: role of histone modification.作者:Kumar P, Periyasamy R, Das S, Neerukonda S, Mani I, Pandey KN;雜志名稱:Mol Pharmacol 標(biāo)題:Elevated expression of histone demethylase PHF8 associates with adverse prognosis in patients of laryngeal and hypopharyngeal squamous cell carcinoma.作者:Zhu G, Liu L, She L, Tan H, Wei M, Chen C, Su Z, Huang D, Tian Y, Qiu Y, Liu Y, Zhang X;雜志名稱:Epigenomics 標(biāo)題:Global quantification of heterochromatin-associated histone methylations in cell lines with differential sensitivity to ionizing radiation.作者:Cetinkaya M, ?–zg??r E, Dalay N, Gezer U;雜志名稱:Acta Biochim Pol 標(biāo)題:Force-induced gene up-regulation does not follow the weak power law but depends on H3K9 demethylation.作者:Sun J, Chen J, Mohagheghian E, Wang N;雜志名稱:Sci Adv 標(biāo)題:Perinatal inflammation alters histone 3 and histone 4 methylation patterns: Effects of MiR-29b supplementation.作者:Sugar SS, Heyob KM, Cheng X, Lee RJ, Rogers LK;雜志名稱:Redox Biol Epigentek 公司是全球領(lǐng)先的表觀遺傳學(xué)相關(guān)研究的技術(shù)創(chuàng)新者和產(chǎn)品開發(fā)供應(yīng)商。開發(fā)了超過700多個專利產(chǎn)品,為表觀遺傳學(xué)方面的研究和新藥研發(fā)提供全面系統(tǒng)的解決方案,涵蓋樣品制備、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、組蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等領(lǐng)域,提供小分子抑制劑、蛋白質(zhì)、抗體、以及分析試劑盒產(chǎn)品。